This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI | MicrobiomeTrials
← Back to trials NCT06333314
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-07-23Est. Completion: 2028-10
Enrollment target: 120 participantsLocations Institut de Cancérologie de l'Ouest, Angers, France Institut du Cancer Avignon-Provence, Avignon, France CHU Jean Minjoz, Besançon, France CHU Morvan, Brest, France Centre François Baclesse, Caen, France Centre Jean Perrin, Clermont-Ferrand, France CHU - Henri Mondor, Créteil, France Centre Georges François Leclerc, Dijon, France Centre Léon Bérard, Lyon, France Hôpital la Timone, Marseille, France Institut Paoli Calmettes, Marseille, France Institut de Cancérologie de Lorraine, Nancy, France Institut Mutualiste Montsouris, Paris, France CHU de Bordeaux - Hôpital Haut -Lèvêque, Pessac, France CHU de Poitiers, Poitiers, France Institut Jean Godinot, Reims, France Centre Eugène Marquis, Rennes, France CHU de Rouen, Rouen, France Institut de Cancérologie de l'Ouest, Saint-Herblain, France CHU de Toulouse Hôpital Rangueil, Toulouse, France Other microbiome trials you might be interested in Metastatic Lung Small Cell Carcinoma Metastatic Malignant Solid Neoplasm Metastatic Neuroendocrine Carcinoma Metastatic Pancreatic Adenocarcinoma Stage III Lung Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Lung Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Lung Small Cell Carcinoma Unresectable Malignant Solid Neoplasm Unresectable Neuroendocrine Carcinoma Unresectable Pancreatic Adenocarcinoma
This phase I trial tests the safety, side effects and best dose of BAY 1895344 when given together with usual chemothera…
Gustave Roussy Grand Paris, Villejuif, France
Hôpital Saint-Antoine, Paris, Île-de-France Region, France Phoenix, United States
Est. completion Feb 15, 2025
Pancreatic Cancer
This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive …
Birmingham, United States Est. completion Mar 2028
Pancreatic Acinar Cell Carcinoma Pancreatic Adenosquamous Carcinoma Pancreatic Squamous Cell Carcinoma Resectable Pancreatic Acinar Cell Carcinoma Resectable Pancreatic Adenocarcinoma Resectable Pancreatic Adenosquamous Carcinoma Resectable Pancreatic Carcinoma
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy work…
Anchorage, United States Est. completion Oct 31, 2027